Imugene appoints cell therapy specialist as new chief operating officer

Imugene Ltd (ASX:IMU, OTC:IUGNF) has appointed cell therapy and biopharmaceutical specialist Dr Bradley Glover as the immune-oncology company’s chief...

Related Keywords

Colorado ,United States ,Bradley Glover ,Leslie Chong ,Rady School Of Management ,Imugene Ltd ,University Of California San Diego ,University Of Colorado ,Molecular Genetics ,Rady School ,California San ,Kite Pharma ,